-
Current through October 23, 2012
(a) Any individual or group health benefit plan, including Medicaid, shall provide health insurance benefits to cover:
(1) A baseline mammogram for women; and
(2) An annual screening mammogram for women.
(b) Any individual or group health benefit plan, including Medicaid, shall provide health insurance benefits to cover:
(1) Annual cervical cytologic screening for women; and
(2) Cervical cytologic screening for women upon certification by an attending physician that the test is medically necessary.
(c) Benefits provided in accordance with this section shall not be subject to an annual or coinsurance deductible.
(d) Benefits provided in accordance with this section shall not be subject to a co-payment except when an enrollee or subscriber elects to have a baseline mammogram, annual screening mammogram, annual cervical cytologic screening, and a cervical cytologic screening certified by an attending physician as being necessary, performed by an out-of-network provider in a preferred provider plan.
(e) Co-payments and coinsurance may be applicable to the enrollee's or subscriber's office visit.
(f) Subsections (d) and (e) of this section shall apply:
(1) To any insurance policy or subscriber contract delivered or issued for delivery in the District more than 120 days after April 5, 2005; and
(2) To any insurance policy or subscriber contract renewed, amended, or reissued 120 days after April 5, 2005.
(Mar. 7, 1991, D.C. Law 8-225, § 3, 38 DCR 217; June 18, 2003, D.C. Law 14-312, § 401(b), 50 DCR 306; Apr. 5, 2005, D.C. Law 15-291, § 2, 52 DCR 1457; Apr. 7, 2006, D.C. Law 16-91, § 106, 52 DCR 10637.)
HISTORICAL AND STATUTORY NOTES
Prior Codifications
1981 Ed., § 35-2402.
Effect of Amendments
D.C. Law 14-312, in subsecs. (a) and (b), substituted "health benefit plan" for "health insurance policy or service".
D.C. Law 15-291 added subsecs. (d), (e), and (f).
D.C. Law 16-91 made a technical correction that resulted in no change in text.
Legislative History of Laws
For legislative history of D.C. Law 8-225, see Historical and Statutory Notes following § 31-2901.
For Law 14-312, see notes following § 31-1601.
Law 15-291, the "Cancer Prevention Amendment Act of 2004", was introduced in Council and assigned Bill No. 15-875, which was referred to the Committee on Consumer and Regulatory Affairs. The Bill was adopted on first and second readings on November 9, 2004, and December 7, 2004, respectively. Signed by the Mayor on December 29, 2004, it was assigned Act No. 15-686 and transmitted to both Houses of Congress for its review. D.C. Law 15-291 became effective on April 5, 2005.
Law 16-91, the "Technical Amendments Act of 2005", was introduced in Council and assigned Bill No. 16-477 which was referred to the Committee on the Whole. The Bill was adopted on first and second readings on November 1, 2005, and November 15, 2005, respectively. Signed by the Mayor on November 30, 2005, it was assigned Act No. 16-212 and transmitted to both Houses of Congress for its review. D.C. Law 16-91 became effective on April 7, 2006.
